177 related articles for article (PubMed ID: 32231271)
1. Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry.
Lauster D; Klenk S; Ludwig K; Nojoumi S; Behren S; Adam L; Stadtmüller M; Saenger S; Zimmler S; Hönzke K; Yao L; Hoffmann U; Bardua M; Hamann A; Witzenrath M; Sander LE; Wolff T; Hocke AC; Hippenstiel S; De Carlo S; Neudecker J; Osterrieder K; Budisa N; Netz RR; Böttcher C; Liese S; Herrmann A; Hackenberger CPR
Nat Nanotechnol; 2020 May; 15(5):373-379. PubMed ID: 32231271
[TBL] [Abstract][Full Text] [Related]
2. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
3. Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus.
Adam L; Müller E; Ludwig K; Klenk S; Lauster D; Liese S; Herrmann A; Hackenberger CPR
Bioconjug Chem; 2022 Jul; 33(7):1269-1278. PubMed ID: 35759354
[TBL] [Abstract][Full Text] [Related]
4. A Sialylated Voltage-Dependent Ca
Fujioka Y; Nishide S; Ose T; Suzuki T; Kato I; Fukuhara H; Fujioka M; Horiuchi K; Satoh AO; Nepal P; Kashiwagi S; Wang J; Horiguchi M; Sato Y; Paudel S; Nanbo A; Miyazaki T; Hasegawa H; Maenaka K; Ohba Y
Cell Host Microbe; 2018 Jun; 23(6):809-818.e5. PubMed ID: 29779930
[TBL] [Abstract][Full Text] [Related]
5. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.
Marvin SA; Russier M; Huerta CT; Russell CJ; Schultz-Cherry S
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807237
[TBL] [Abstract][Full Text] [Related]
6. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
Matsubara T; Onishi A; Yamaguchi D; Sato T
Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
[TBL] [Abstract][Full Text] [Related]
7. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.
Holthausen DJ; Lee SH; Kumar VT; Bouvier NM; Krammer F; Ellebedy AH; Wrammert J; Lowen AC; George S; Pillai MR; Jacob J
Immunity; 2017 Apr; 46(4):587-595. PubMed ID: 28423338
[TBL] [Abstract][Full Text] [Related]
8. Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors.
Nie C; Stadtmüller M; Parshad B; Wallert M; Ahmadi V; Kerkhoff Y; Bhatia S; Block S; Cheng C; Wolff T; Haag R
Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33523846
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus uses mGluR2 as an endocytic receptor to enter cells.
Ni Z; Wang J; Yu X; Wang Y; Wang J; He X; Li C; Deng G; Shi J; Kong H; Jiang Y; Chen P; Zeng X; Tian G; Chen H; Bu Z
Nat Microbiol; 2024 Jul; 9(7):1764-1777. PubMed ID: 38849624
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
12. N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis.
Sriwilaijaroen N; Nakakita SI; Kondo S; Yagi H; Kato K; Murata T; Hiramatsu H; Kawahara T; Watanabe Y; Kanai Y; Ono T; Hirabayashi J; Matsumoto K; Suzuki Y
FEBS J; 2018 May; 285(9):1611-1634. PubMed ID: 29542865
[TBL] [Abstract][Full Text] [Related]
13. Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection.
Mebratu YA; Tipper J; Chand HS; Walton S; Harrod KS; Tesfaigzi Y
Am J Respir Cell Mol Biol; 2016 May; 54(5):664-73. PubMed ID: 26437021
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
15. Influenza A virus uses the aggresome processing machinery for host cell entry.
Banerjee I; Miyake Y; Nobs SP; Schneider C; Horvath P; Kopf M; Matthias P; Helenius A; Yamauchi Y
Science; 2014 Oct; 346(6208):473-7. PubMed ID: 25342804
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
Winarski KL; Tang J; Klenow L; Lee J; Coyle EM; Manischewitz J; Turner HL; Takeda K; Ward AB; Golding H; Khurana S
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15194-15199. PubMed ID: 31296560
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
19. An overview of influenza A virus receptors.
Ge S; Wang Z
Crit Rev Microbiol; 2011 May; 37(2):157-65. PubMed ID: 21438845
[TBL] [Abstract][Full Text] [Related]
20. Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin.
Sato Y; Morimoto K; Kubo T; Sakaguchi T; Nishizono A; Hirayama M; Hori K
Mar Drugs; 2015 May; 13(6):3454-65. PubMed ID: 26035023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
